Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WAT
Waters Corp.
|
$783M | $3.22 | 6.4% | 16.31% | $406.34 |
|
CTSO
CytoSorbents Corp.
|
$10M | -$0.07 | 51.05% | -41.38% | $4.92 |
|
DCTH
Delcath Systems, Inc.
|
$25.3M | -$0.09 | 32.37% | -69.37% | $22.31 |
|
ILMN
Illumina, Inc.
|
$1.1B | $1.17 | -0.1% | 4.82% | $125.28 |
|
MTD
Mettler-Toledo International, Inc.
|
$997.4M | $10.66 | 5.7% | 7.05% | $1,495.69 |
|
STRR
Star Operating Cos., Inc.
|
$16.8M | -$0.76 | 50.04% | -65.48% | $12.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WAT
Waters Corp.
|
$383.21 | $406.34 | $22.8B | 35.23x | $0.00 | 0% | 7.36x |
|
CTSO
CytoSorbents Corp.
|
$0.69 | $4.92 | $43.3M | -- | $0.00 | 0% | 1.23x |
|
DCTH
Delcath Systems, Inc.
|
$10.32 | $22.31 | $364.4M | 1,186.21x | $0.00 | 0% | 4.92x |
|
ILMN
Illumina, Inc.
|
$136.19 | $125.28 | $20.8B | 30.51x | $0.00 | 0% | 5.01x |
|
MTD
Mettler-Toledo International, Inc.
|
$1,414.60 | $1,495.69 | $28.9B | 35.28x | $0.00 | 0% | 7.48x |
|
STRR
Star Operating Cos., Inc.
|
$10.90 | $12.00 | $37.5M | 0.75x | $0.00 | 0% | 0.52x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WAT
Waters Corp.
|
38.94% | 0.581 | 8.33% | 0.98x |
|
CTSO
CytoSorbents Corp.
|
75.25% | 1.075 | 46.74% | 1.49x |
|
DCTH
Delcath Systems, Inc.
|
0.83% | 1.825 | 0.25% | 12.82x |
|
ILMN
Illumina, Inc.
|
51.97% | 2.433 | 17.73% | 1.04x |
|
MTD
Mettler-Toledo International, Inc.
|
112.71% | 1.348 | 8.81% | 0.65x |
|
STRR
Star Operating Cos., Inc.
|
26.85% | 8.871 | 70.75% | 0.76x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WAT
Waters Corp.
|
$460.9M | $193.1M | 17.97% | 32.82% | 24.14% | $161.9M |
|
CTSO
CytoSorbents Corp.
|
$6.7M | -$2.7M | -27.15% | -89.32% | -28.07% | -$2.5M |
|
DCTH
Delcath Systems, Inc.
|
$17.9M | -$388K | 1.56% | 1.59% | -1.89% | $4.3M |
|
ILMN
Illumina, Inc.
|
$732M | $231M | 14.3% | 30.55% | 21.33% | $253M |
|
MTD
Mettler-Toledo International, Inc.
|
$589.4M | $289.9M | 43.06% | -- | 28.15% | $274.9M |
|
STRR
Star Operating Cos., Inc.
|
$5.6M | -$866K | -2.74% | -3.67% | -3.65% | -$2.4M |
CytoSorbents Corp. has a net margin of 18.62% compared to Waters Corp.'s net margin of -33.42%. Waters Corp.'s return on equity of 32.82% beat CytoSorbents Corp.'s return on equity of -89.32%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WAT
Waters Corp.
|
57.63% | $2.50 | $3.8B |
|
CTSO
CytoSorbents Corp.
|
70.28% | -$0.05 | $36.4M |
Waters Corp. has a consensus price target of $406.34, signalling upside risk potential of 6.04%. On the other hand CytoSorbents Corp. has an analysts' consensus of $4.92 which suggests that it could grow by 613.18%. Given that CytoSorbents Corp. has higher upside potential than Waters Corp., analysts believe CytoSorbents Corp. is more attractive than Waters Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WAT
Waters Corp.
|
6 | 10 | 0 |
|
CTSO
CytoSorbents Corp.
|
1 | 1 | 0 |
Waters Corp. has a beta of 1.162, which suggesting that the stock is 16.247% more volatile than S&P 500. In comparison CytoSorbents Corp. has a beta of 1.285, suggesting its more volatile than the S&P 500 by 28.454%.
Waters Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters Corp. pays -- of its earnings as a dividend. CytoSorbents Corp. pays out -- of its earnings as a dividend.
Waters Corp. quarterly revenues are $799.9M, which are larger than CytoSorbents Corp. quarterly revenues of $9.5M. Waters Corp.'s net income of $148.9M is higher than CytoSorbents Corp.'s net income of -$3.2M. Notably, Waters Corp.'s price-to-earnings ratio is 35.23x while CytoSorbents Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters Corp. is 7.36x versus 1.23x for CytoSorbents Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WAT
Waters Corp.
|
7.36x | 35.23x | $799.9M | $148.9M |
|
CTSO
CytoSorbents Corp.
|
1.23x | -- | $9.5M | -$3.2M |
Delcath Systems, Inc. has a net margin of 18.62% compared to Waters Corp.'s net margin of 4.04%. Waters Corp.'s return on equity of 32.82% beat Delcath Systems, Inc.'s return on equity of 1.59%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WAT
Waters Corp.
|
57.63% | $2.50 | $3.8B |
|
DCTH
Delcath Systems, Inc.
|
87.24% | $0.02 | $115.8M |
Waters Corp. has a consensus price target of $406.34, signalling upside risk potential of 6.04%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.31 which suggests that it could grow by 116.13%. Given that Delcath Systems, Inc. has higher upside potential than Waters Corp., analysts believe Delcath Systems, Inc. is more attractive than Waters Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WAT
Waters Corp.
|
6 | 10 | 0 |
|
DCTH
Delcath Systems, Inc.
|
5 | 0 | 0 |
Waters Corp. has a beta of 1.162, which suggesting that the stock is 16.247% more volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.410, suggesting its less volatile than the S&P 500 by 59.033%.
Waters Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters Corp. pays -- of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend.
Waters Corp. quarterly revenues are $799.9M, which are larger than Delcath Systems, Inc. quarterly revenues of $20.6M. Waters Corp.'s net income of $148.9M is higher than Delcath Systems, Inc.'s net income of $830K. Notably, Waters Corp.'s price-to-earnings ratio is 35.23x while Delcath Systems, Inc.'s PE ratio is 1,186.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters Corp. is 7.36x versus 4.92x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WAT
Waters Corp.
|
7.36x | 35.23x | $799.9M | $148.9M |
|
DCTH
Delcath Systems, Inc.
|
4.92x | 1,186.21x | $20.6M | $830K |
Illumina, Inc. has a net margin of 18.62% compared to Waters Corp.'s net margin of 13.85%. Waters Corp.'s return on equity of 32.82% beat Illumina, Inc.'s return on equity of 30.55%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WAT
Waters Corp.
|
57.63% | $2.50 | $3.8B |
|
ILMN
Illumina, Inc.
|
67.59% | $0.97 | $5B |
Waters Corp. has a consensus price target of $406.34, signalling upside risk potential of 6.04%. On the other hand Illumina, Inc. has an analysts' consensus of $125.28 which suggests that it could fall by -8.01%. Given that Waters Corp. has higher upside potential than Illumina, Inc., analysts believe Waters Corp. is more attractive than Illumina, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WAT
Waters Corp.
|
6 | 10 | 0 |
|
ILMN
Illumina, Inc.
|
7 | 8 | 1 |
Waters Corp. has a beta of 1.162, which suggesting that the stock is 16.247% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.438, suggesting its more volatile than the S&P 500 by 43.845%.
Waters Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters Corp. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.
Waters Corp. quarterly revenues are $799.9M, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. Waters Corp.'s net income of $148.9M is lower than Illumina, Inc.'s net income of $150M. Notably, Waters Corp.'s price-to-earnings ratio is 35.23x while Illumina, Inc.'s PE ratio is 30.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters Corp. is 7.36x versus 5.01x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WAT
Waters Corp.
|
7.36x | 35.23x | $799.9M | $148.9M |
|
ILMN
Illumina, Inc.
|
5.01x | 30.51x | $1.1B | $150M |
Mettler-Toledo International, Inc. has a net margin of 18.62% compared to Waters Corp.'s net margin of 21.12%. Waters Corp.'s return on equity of 32.82% beat Mettler-Toledo International, Inc.'s return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WAT
Waters Corp.
|
57.63% | $2.50 | $3.8B |
|
MTD
Mettler-Toledo International, Inc.
|
57.24% | $10.57 | $2B |
Waters Corp. has a consensus price target of $406.34, signalling upside risk potential of 6.04%. On the other hand Mettler-Toledo International, Inc. has an analysts' consensus of $1,495.69 which suggests that it could grow by 5.73%. Given that Waters Corp. has higher upside potential than Mettler-Toledo International, Inc., analysts believe Waters Corp. is more attractive than Mettler-Toledo International, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WAT
Waters Corp.
|
6 | 10 | 0 |
|
MTD
Mettler-Toledo International, Inc.
|
4 | 9 | 0 |
Waters Corp. has a beta of 1.162, which suggesting that the stock is 16.247% more volatile than S&P 500. In comparison Mettler-Toledo International, Inc. has a beta of 1.397, suggesting its more volatile than the S&P 500 by 39.716%.
Waters Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mettler-Toledo International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters Corp. pays -- of its earnings as a dividend. Mettler-Toledo International, Inc. pays out -- of its earnings as a dividend.
Waters Corp. quarterly revenues are $799.9M, which are smaller than Mettler-Toledo International, Inc. quarterly revenues of $1B. Waters Corp.'s net income of $148.9M is lower than Mettler-Toledo International, Inc.'s net income of $217.5M. Notably, Waters Corp.'s price-to-earnings ratio is 35.23x while Mettler-Toledo International, Inc.'s PE ratio is 35.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters Corp. is 7.36x versus 7.48x for Mettler-Toledo International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WAT
Waters Corp.
|
7.36x | 35.23x | $799.9M | $148.9M |
|
MTD
Mettler-Toledo International, Inc.
|
7.48x | 35.28x | $1B | $217.5M |
Star Operating Cos., Inc. has a net margin of 18.62% compared to Waters Corp.'s net margin of 14.56%. Waters Corp.'s return on equity of 32.82% beat Star Operating Cos., Inc.'s return on equity of -3.67%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WAT
Waters Corp.
|
57.63% | $2.50 | $3.8B |
|
STRR
Star Operating Cos., Inc.
|
23.43% | $0.86 | $85.6M |
Waters Corp. has a consensus price target of $406.34, signalling upside risk potential of 6.04%. On the other hand Star Operating Cos., Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 10.09%. Given that Star Operating Cos., Inc. has higher upside potential than Waters Corp., analysts believe Star Operating Cos., Inc. is more attractive than Waters Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WAT
Waters Corp.
|
6 | 10 | 0 |
|
STRR
Star Operating Cos., Inc.
|
1 | 1 | 0 |
Waters Corp. has a beta of 1.162, which suggesting that the stock is 16.247% more volatile than S&P 500. In comparison Star Operating Cos., Inc. has a beta of 2.714, suggesting its more volatile than the S&P 500 by 171.399%.
Waters Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Operating Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters Corp. pays -- of its earnings as a dividend. Star Operating Cos., Inc. pays out 19.54% of its earnings as a dividend. Star Operating Cos., Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Waters Corp. quarterly revenues are $799.9M, which are larger than Star Operating Cos., Inc. quarterly revenues of $23.7M. Waters Corp.'s net income of $148.9M is higher than Star Operating Cos., Inc.'s net income of $3.5M. Notably, Waters Corp.'s price-to-earnings ratio is 35.23x while Star Operating Cos., Inc.'s PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters Corp. is 7.36x versus 0.52x for Star Operating Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WAT
Waters Corp.
|
7.36x | 35.23x | $799.9M | $148.9M |
|
STRR
Star Operating Cos., Inc.
|
0.52x | 0.75x | $23.7M | $3.5M |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.